Meropenem And Sodium Chloride Injection, Solution
Product Images NDC 0264-3183

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Meropenem And Sodium Chloride (NDC 0264-3183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Diagram 1 (Meropenem In Duplex 1)

Diagram 1 (Meropenem In Duplex 1)
FDA Label Image

Diagram 2 (Meropenem In Duplex 2)

Diagram 2 (Meropenem In Duplex 2)
FDA Label Image

Diagram 3 (Meropenem In Duplex 3)

Diagram 3 (Meropenem In Duplex 3)
FDA Label Image

Diagram 4 (Meropenem In Duplex 4)

Diagram 4 (Meropenem In Duplex 4)
FDA Label Image

Diagram 5 (Meropenem In Duplex 5)

Diagram 5 (Meropenem In Duplex 5)
FDA Label Image

Structural Formula (Meropenem In Duplex 6)

Structural Formula (Meropenem In Duplex 6)
FDA Label Image

500 mg 50ml Container Label (Meropenem In Duplex 7)

500 mg 50ml Container Label (Meropenem In Duplex 7)
FDA Label Image

1g 50ml Container Label (Meropenem In Duplex 8)

1g 50ml Container Label (Meropenem In Duplex 8)
Meropenem for injection is an antibiotic drug that is used for intravenous infusion only. The drug comes in a DUPLEX container which must be used only after mixing the contents of both chambers. Once reconstituted, each 50mL single-dose unit contains sterile meropenem trihydrate USP with a total sodium content of 290.2 mg. Prior to reconstitution, the drug must be stored at 20°C-25°C, and after reconstitution, the solution must be clear and free from particulate matter before use. The product must be used within seven days of removing the foil strip, and not beyond the labeled expiration date. The container must be protected from light after removal of the foil strip. The drug has not been manufactured with natural rubber latex, PVC, or DEHP.*
FDA Label Image

Drug Chamber (Meropenem In Duplex 9)

Drug Chamber (Meropenem In Duplex 9)
The text is a set of instructions related to a drug chamber. It suggests discarding the unit if the foil strip is damaged and visually inspecting the drug before reconstitution. The package insert should be referred to for detailed directions on reconstitution and administration. The text includes a reference number "I3" and a product code "yar001-485".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.